Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Grows By 8.3%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 15,600 shares, an increase of 8.3% from the October 31st total of 14,400 shares. Based on an average daily trading volume, of 92,100 shares, the days-to-cover ratio is currently 0.2 days.

CERo Therapeutics Stock Performance

Shares of NASDAQ CEROW traded down $0.00 during mid-day trading on Wednesday, reaching $0.01. The company’s stock had a trading volume of 21,299 shares, compared to its average volume of 68,257. The stock has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.02. CERo Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.